Clinical Trials

CNSOther hematologic neoplasm

58 enrolled

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT07192120 2026-04-09

A Study of MHB048C in Patients With Advanced Solid Tumors

GenitourinaryOther solid neoplasm

200 enrolled

mCRPC (Metastatic Castration-resistant Prostate Cancer)

NCT04049539 2026-04-08

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Other hematologic neoplasm

28 enrolled

Leukemia, Myeloid, Acute

NCT06431490 2026-04-08

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

102 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT07222969 2026-03-23

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

146 enrolled

Advanced Solid Tumors

NCT06481735 2026-03-16

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06821503 2026-03-10

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

72 enrolled

Gastrointestinal

Advanced Pancreatic Cancer

NCT07069062 2026-03-09

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

261 enrolled

Solid Tumor

NCT07042802 2026-03-06

A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

110 enrolled

Gynecologic

Ovarian Neoplasms

NCT04752826 2026-02-18

MK-3475-D20

DermatologicGynecologicLymphoid

176 enrolled

Melanoma, Ovarian Neoplasms, Lymphoma, T-Cell

NCT07208149 2026-02-12

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

42 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07281976 2026-02-12

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

220 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06580301 2026-02-06

Study of YK012 in B-cell Acute Lymphoblastic Leukemia

46 enrolled

Burkitt Lymphoma

NCT07112222 2026-01-26

A Study of LM-350 in Subjects With Advanced Solid Tumours

80 enrolled

Tumor-Agnostic

Neoplasms

NCT03661307 2026-01-12

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

73 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05584800 2026-01-05

Study of ZGGS18 in Patients With Advanced Solid Tumors

222 enrolled

Advanced Solid Tumor

NCT06883526 2026-01-05

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

60 enrolled

Lymphoma

NCT06903377 2026-01-05

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06938880 2026-01-05

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

60 enrolled

Advanced Solid Tumor

NCT06512051 2025-12-23

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

248 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07229586 2025-12-19

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

100 enrolled

Solid Tumor

NCT04128748 2025-12-17

Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

52 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06049290 2025-12-04

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

342 enrolled

Plasma cell

Multiple Myeloma

NCT06840821 2025-12-02

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

156 enrolled

Advanced Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

312 enrolled

Solid Tumors

NCT07083323 2025-11-25

A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors

262 enrolled

Advanced Solid Tumor

NCT04707300 2025-11-20

HTLP-ONCO

Other hematologic neoplasm

10 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual, Hematologic Neoplasms

NCT07126665 2025-11-18

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

116 enrolled

Advanced Malignant Solid Tumor

NCT07229599 2025-11-17

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

300 enrolled

Thoracic

Advanced Lung Cancer

NCT06928662 2025-11-06

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

MyeloidOther hematologic neoplasm

36 enrolled

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06840002 2025-09-30

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer

150 enrolled

Gynecologic

Ovarian Neoplasms

NCT07169994 2025-09-12

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

414 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06209580 2025-09-05

AMT-253 in Patients With Advanced Solid Tumours

96 enrolled

Dermatologic

Melanoma

NCT06376136 2025-08-13

A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

216 enrolled

Advanced Solid Tumors

NCT05554939 2025-08-06

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

Lymphoma, Non-Hodgkin, Recurrence

NCT07102004 2025-08-03

Study of MHB088C for Patients With Advanced Solid Malignant Tumors

515 enrolled

Advanced/Metastatic Solid Tumors

NCT06838832 2025-07-30

Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL

Recurrence

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

306 enrolled

Advanced Solid Tumors

NCT07008885 2025-06-25

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07009002 2025-06-25

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Lymphoma, B-Cell

NCT06888830 2025-06-19

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour

374 enrolled

Advanced Malignant Solid Tumours

NCT06014073 2025-05-25

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Lymphoma, Non-Hodgkin

NCT06323525 2025-05-25

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Lymphoma, Non-Hodgkin

NCT05170958 2025-05-22

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

396 enrolled

Advanced Solid Tumor

NCT05779163 2025-05-07

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

468 enrolled

Advanced Malignant Tumors

NCT05438329 2025-02-27

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

1,123 enrolled

Advanced Solid Tumor

NCT06038396 2025-01-29

A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

48 enrolled

Advanced Solid Tumor

NCT05205850 2025-01-27

A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

135 enrolled